Tech Company Financing Transactions
Cleerly Funding Round
Cleerly closed a $192 million Series C funding round on 7/25/2022. Backers included T. Rowe Price, Breyer Capital and Cigna.
Transaction Overview
Company Name
Announced On
7/25/2022
Transaction Type
Venture Equity
Amount
$192,000,000
Round
Series C
Investors
Proceeds Purpose
This funding round will enable Cleerly to expand its team as well as extend its commercial reach to broaden patient and physician access to its comprehensive technology-enabled care pathway across the entire continuum of disease presentation--from early diagnosis of heart disease to ensuring that ongoing treatments are effective for those who have that elevated risk or symptoms.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
101 Greenwich St.
New York, NY 10006
USA
New York, NY 10006
USA
Phone
Website
Email Address
Overview
Cleerly enables comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging. Cleerly's digital care pathway leverages non-invasive coronary computed tomography (CT) angiography to perform comprehensive coronary artery phenotyping through AI-enabled and FDA-cleared solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Min
Browse more venture capital transactions:
Prev: 7/25/2022: Coinzix venture capital transaction
Next: 7/25/2022: Everside Health venture capital transaction
Share this article
About Our VC Transactions Data
We report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs